ProVise Management Group LLC trimmed its position in shares of Mazor Robotics Ltd – (NASDAQ:MZOR) by 15.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 11,329 shares of the medical instruments supplier’s stock after selling 2,066 shares during the period. ProVise Management Group LLC’s holdings in Mazor Robotics were worth $585,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in MZOR. Ark Investment Management LLC boosted its stake in shares of Mazor Robotics by 104.9% in the 2nd quarter. Ark Investment Management LLC now owns 21,410 shares of the medical instruments supplier’s stock valued at $740,000 after purchasing an additional 10,962 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Mazor Robotics by 8.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 8,570 shares of the medical instruments supplier’s stock valued at $296,000 after purchasing an additional 641 shares in the last quarter. Royal Bank of Canada boosted its stake in shares of Mazor Robotics by 9.2% in the 2nd quarter. Royal Bank of Canada now owns 21,663 shares of the medical instruments supplier’s stock valued at $749,000 after purchasing an additional 1,819 shares in the last quarter. Raymond James Financial Services Advisors Inc. acquired a new stake in shares of Mazor Robotics in the 2nd quarter valued at approximately $770,000. Finally, Lord Abbett & CO. LLC acquired a new stake in shares of Mazor Robotics in the 2nd quarter valued at approximately $2,421,000. Hedge funds and other institutional investors own 26.40% of the company’s stock.

MZOR has been the topic of a number of research analyst reports. Zacks Investment Research upgraded shares of Mazor Robotics from a “hold” rating to a “buy” rating and set a $61.00 price target on the stock in a research note on Wednesday, December 13th. Barclays downgraded shares of Mazor Robotics from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $55.00 to $34.00 in a research note on Thursday, October 19th. BidaskClub downgraded shares of Mazor Robotics from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 2nd. TheStreet upgraded shares of Mazor Robotics from a “d” rating to a “c-” rating in a research note on Wednesday, November 8th. Finally, Needham & Company LLC restated a “hold” rating on shares of Mazor Robotics in a research note on Tuesday, November 7th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. Mazor Robotics presently has an average rating of “Hold” and an average target price of $45.67.

Mazor Robotics Ltd – (MZOR) opened at $59.53 on Thursday. Mazor Robotics Ltd – has a fifty-two week low of $21.55 and a fifty-two week high of $69.37.

Mazor Robotics (NASDAQ:MZOR) last issued its quarterly earnings data on Wednesday, February 14th. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.09. The business had revenue of $19.15 million during the quarter, compared to analyst estimates of $19.00 million. Mazor Robotics had a negative net margin of 28.80% and a negative return on equity of 22.68%. The firm’s quarterly revenue was up 36.4% on a year-over-year basis. During the same quarter last year, the business earned ($0.07) EPS. sell-side analysts forecast that Mazor Robotics Ltd – will post -0.72 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “ProVise Management Group LLC Has $585,000 Holdings in Mazor Robotics Ltd – (MZOR)” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/02/15/provise-management-group-llc-has-585000-holdings-in-mazor-robotics-ltd-mzor.html.

Mazor Robotics Profile

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Want to see what other hedge funds are holding MZOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mazor Robotics Ltd – (NASDAQ:MZOR).

Institutional Ownership by Quarter for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.